Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Our peptide therapies are carefully selected for their safety, efficacy, and alignment with our clean, wellness-driven philosophy
Drug overdose deaths involving xylazine have multiplied over the past few years
The alignment of regulatory frameworks with clinical guidelines further supports the adoption of GLP-1 drugs, indicating a positive trajectory for the market in the coming years
While small quantities are generally safe, larger amounts can lead to adverse effects
Approximately 3% to 4% of patients will discontinue treatment because of gastrointestinal adverse effects
Oral GLP-1 small molecules are not guaranteed winners, because they must still clear exposure, liver safety, and gastrointestinal-tolerability hurdles
US$ 23.17
US$ 20.90
US$ 21.70
